Clinical characteristics of patients with community-acquired complicated intra-abdominal infections: a prospective, multicentre, observational study

Shio Shin Jean, Wen Chien Ko, Yang Xie, Vaishali Pawar, Dongmu Zhang, Girish Prajapati, Myrna Mendoza, Pattarachai Kiratisin, Elmano Ramalheira, Ana P.aula Castro, Fernando Rosso, Po Ren Hsueh

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

In this prospective, observational, multicentre study using data from five countries (Columbia, The Philippines, Portugal, Taiwan and Thailand), the clinical impact of extended-spectrum β-lactamase (ESBL)-producing organisms on hospitalised patients with community-acquired complicated intra-abdominal infections (CA-cIAIs) was compared with that of non-ESBL-producing organisms during the period April 2010 to December 2011. Adult patients (aged ≥18 years) requiring surgery or percutaneous drainage were enrolled and were followed during the first hospitalisation course. An unadjusted statistical comparison of risk factors for ESBL-positive and ESBL-negative patients was performed. Multivariate regression analyses were performed to assess whether length of stay (LOS) in hospital, clinical cure rate and some important clinical characteristics were associated with ESBL positivity. During the study period, a total of 105 adult patients from five countries were enrolled, of whom 17 (16.2%) had CA-cIAI due to ESBL-positive organisms and 88 (83.8%) had CA-cIAI due to ESBL-negative organisms. Escherichia coli was isolated in 73.3% of all samples. Infections were cured in 8 (47.1%) of the patients with CA-cIAI due to ESBL-positive organisms and in 59 (67.0%) of the patients with CA-cIAI due to ESBL-negative organisms (P=0.285). The median LOS was 11.6 days for patients with infections due to ESBL-negative organisms and 17.6 days for patients with infections due to ESBL-positive organisms (P=0.011). Multivariate logistic regression analysis revealed that pre-existing co-morbidities, but not ESBL positivity, were adversely associated with clinical cure of CA-cIAIs. In contrast, duration of hospitalisation was longer for patients with CA-cIAI due to ESBL-positive organisms.

Original languageEnglish
Pages (from-to)222-228
Number of pages7
JournalInternational Journal of Antimicrobial Agents
Volume44
Issue number3
DOIs
Publication statusPublished - Sep 1 2014

Fingerprint

Intraabdominal Infections
Multicenter Studies
Observational Studies
Length of Stay
Hospitalization
Infection
Regression Analysis
Philippines
Portugal
Thailand
Taiwan
Drainage
Multivariate Analysis
Logistic Models
Escherichia coli
Morbidity

Keywords

  • Community-acquired complicated intra-abdominal infection
  • ESBL
  • Extended-spectrum β-lactamase
  • Length of stay
  • Outcomes

ASJC Scopus subject areas

  • Microbiology (medical)
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

Clinical characteristics of patients with community-acquired complicated intra-abdominal infections : a prospective, multicentre, observational study. / Jean, Shio Shin; Ko, Wen Chien; Xie, Yang; Pawar, Vaishali; Zhang, Dongmu; Prajapati, Girish; Mendoza, Myrna; Kiratisin, Pattarachai; Ramalheira, Elmano; Castro, Ana P.aula; Rosso, Fernando; Hsueh, Po Ren.

In: International Journal of Antimicrobial Agents, Vol. 44, No. 3, 01.09.2014, p. 222-228.

Research output: Contribution to journalArticle

Jean, SS, Ko, WC, Xie, Y, Pawar, V, Zhang, D, Prajapati, G, Mendoza, M, Kiratisin, P, Ramalheira, E, Castro, APA, Rosso, F & Hsueh, PR 2014, 'Clinical characteristics of patients with community-acquired complicated intra-abdominal infections: a prospective, multicentre, observational study', International Journal of Antimicrobial Agents, vol. 44, no. 3, pp. 222-228. https://doi.org/10.1016/j.ijantimicag.2014.05.018
Jean, Shio Shin ; Ko, Wen Chien ; Xie, Yang ; Pawar, Vaishali ; Zhang, Dongmu ; Prajapati, Girish ; Mendoza, Myrna ; Kiratisin, Pattarachai ; Ramalheira, Elmano ; Castro, Ana P.aula ; Rosso, Fernando ; Hsueh, Po Ren. / Clinical characteristics of patients with community-acquired complicated intra-abdominal infections : a prospective, multicentre, observational study. In: International Journal of Antimicrobial Agents. 2014 ; Vol. 44, No. 3. pp. 222-228.
@article{3901ea02d0c64edf81b6e690518e3c94,
title = "Clinical characteristics of patients with community-acquired complicated intra-abdominal infections: a prospective, multicentre, observational study",
abstract = "In this prospective, observational, multicentre study using data from five countries (Columbia, The Philippines, Portugal, Taiwan and Thailand), the clinical impact of extended-spectrum β-lactamase (ESBL)-producing organisms on hospitalised patients with community-acquired complicated intra-abdominal infections (CA-cIAIs) was compared with that of non-ESBL-producing organisms during the period April 2010 to December 2011. Adult patients (aged ≥18 years) requiring surgery or percutaneous drainage were enrolled and were followed during the first hospitalisation course. An unadjusted statistical comparison of risk factors for ESBL-positive and ESBL-negative patients was performed. Multivariate regression analyses were performed to assess whether length of stay (LOS) in hospital, clinical cure rate and some important clinical characteristics were associated with ESBL positivity. During the study period, a total of 105 adult patients from five countries were enrolled, of whom 17 (16.2{\%}) had CA-cIAI due to ESBL-positive organisms and 88 (83.8{\%}) had CA-cIAI due to ESBL-negative organisms. Escherichia coli was isolated in 73.3{\%} of all samples. Infections were cured in 8 (47.1{\%}) of the patients with CA-cIAI due to ESBL-positive organisms and in 59 (67.0{\%}) of the patients with CA-cIAI due to ESBL-negative organisms (P=0.285). The median LOS was 11.6 days for patients with infections due to ESBL-negative organisms and 17.6 days for patients with infections due to ESBL-positive organisms (P=0.011). Multivariate logistic regression analysis revealed that pre-existing co-morbidities, but not ESBL positivity, were adversely associated with clinical cure of CA-cIAIs. In contrast, duration of hospitalisation was longer for patients with CA-cIAI due to ESBL-positive organisms.",
keywords = "Community-acquired complicated intra-abdominal infection, ESBL, Extended-spectrum β-lactamase, Length of stay, Outcomes",
author = "Jean, {Shio Shin} and Ko, {Wen Chien} and Yang Xie and Vaishali Pawar and Dongmu Zhang and Girish Prajapati and Myrna Mendoza and Pattarachai Kiratisin and Elmano Ramalheira and Castro, {Ana P.aula} and Fernando Rosso and Hsueh, {Po Ren}",
year = "2014",
month = "9",
day = "1",
doi = "10.1016/j.ijantimicag.2014.05.018",
language = "English",
volume = "44",
pages = "222--228",
journal = "International Journal of Antimicrobial Agents",
issn = "0924-8579",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Clinical characteristics of patients with community-acquired complicated intra-abdominal infections

T2 - a prospective, multicentre, observational study

AU - Jean, Shio Shin

AU - Ko, Wen Chien

AU - Xie, Yang

AU - Pawar, Vaishali

AU - Zhang, Dongmu

AU - Prajapati, Girish

AU - Mendoza, Myrna

AU - Kiratisin, Pattarachai

AU - Ramalheira, Elmano

AU - Castro, Ana P.aula

AU - Rosso, Fernando

AU - Hsueh, Po Ren

PY - 2014/9/1

Y1 - 2014/9/1

N2 - In this prospective, observational, multicentre study using data from five countries (Columbia, The Philippines, Portugal, Taiwan and Thailand), the clinical impact of extended-spectrum β-lactamase (ESBL)-producing organisms on hospitalised patients with community-acquired complicated intra-abdominal infections (CA-cIAIs) was compared with that of non-ESBL-producing organisms during the period April 2010 to December 2011. Adult patients (aged ≥18 years) requiring surgery or percutaneous drainage were enrolled and were followed during the first hospitalisation course. An unadjusted statistical comparison of risk factors for ESBL-positive and ESBL-negative patients was performed. Multivariate regression analyses were performed to assess whether length of stay (LOS) in hospital, clinical cure rate and some important clinical characteristics were associated with ESBL positivity. During the study period, a total of 105 adult patients from five countries were enrolled, of whom 17 (16.2%) had CA-cIAI due to ESBL-positive organisms and 88 (83.8%) had CA-cIAI due to ESBL-negative organisms. Escherichia coli was isolated in 73.3% of all samples. Infections were cured in 8 (47.1%) of the patients with CA-cIAI due to ESBL-positive organisms and in 59 (67.0%) of the patients with CA-cIAI due to ESBL-negative organisms (P=0.285). The median LOS was 11.6 days for patients with infections due to ESBL-negative organisms and 17.6 days for patients with infections due to ESBL-positive organisms (P=0.011). Multivariate logistic regression analysis revealed that pre-existing co-morbidities, but not ESBL positivity, were adversely associated with clinical cure of CA-cIAIs. In contrast, duration of hospitalisation was longer for patients with CA-cIAI due to ESBL-positive organisms.

AB - In this prospective, observational, multicentre study using data from five countries (Columbia, The Philippines, Portugal, Taiwan and Thailand), the clinical impact of extended-spectrum β-lactamase (ESBL)-producing organisms on hospitalised patients with community-acquired complicated intra-abdominal infections (CA-cIAIs) was compared with that of non-ESBL-producing organisms during the period April 2010 to December 2011. Adult patients (aged ≥18 years) requiring surgery or percutaneous drainage were enrolled and were followed during the first hospitalisation course. An unadjusted statistical comparison of risk factors for ESBL-positive and ESBL-negative patients was performed. Multivariate regression analyses were performed to assess whether length of stay (LOS) in hospital, clinical cure rate and some important clinical characteristics were associated with ESBL positivity. During the study period, a total of 105 adult patients from five countries were enrolled, of whom 17 (16.2%) had CA-cIAI due to ESBL-positive organisms and 88 (83.8%) had CA-cIAI due to ESBL-negative organisms. Escherichia coli was isolated in 73.3% of all samples. Infections were cured in 8 (47.1%) of the patients with CA-cIAI due to ESBL-positive organisms and in 59 (67.0%) of the patients with CA-cIAI due to ESBL-negative organisms (P=0.285). The median LOS was 11.6 days for patients with infections due to ESBL-negative organisms and 17.6 days for patients with infections due to ESBL-positive organisms (P=0.011). Multivariate logistic regression analysis revealed that pre-existing co-morbidities, but not ESBL positivity, were adversely associated with clinical cure of CA-cIAIs. In contrast, duration of hospitalisation was longer for patients with CA-cIAI due to ESBL-positive organisms.

KW - Community-acquired complicated intra-abdominal infection

KW - ESBL

KW - Extended-spectrum β-lactamase

KW - Length of stay

KW - Outcomes

UR - http://www.scopus.com/inward/record.url?scp=85027935907&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027935907&partnerID=8YFLogxK

U2 - 10.1016/j.ijantimicag.2014.05.018

DO - 10.1016/j.ijantimicag.2014.05.018

M3 - Article

C2 - 25106073

AN - SCOPUS:85027935907

VL - 44

SP - 222

EP - 228

JO - International Journal of Antimicrobial Agents

JF - International Journal of Antimicrobial Agents

SN - 0924-8579

IS - 3

ER -